COGA: Action items from August 27

Hello,

We spent the call today talking about the time-sensitive agenda items that came up this week.

Publication of the updated WCAG 3 Working Draft is now targeted for early September. As part of our normal publishing process a Pre-Call for Consensus (Pre-CFC) for Section 3 and 4 are being sent out this week for feedback by Sunday night.


Timing is tight, but that is because we’ve had a very full summer of wrangling all of the ideas and needs contained in these two sections. That has challenged us to meet our goal of publishing two working draft versions a year.

---

NOTE - As we head into our COGA summer break, please do not feel that you need to drop everything and conduct a detailed review. The purpose of the Pre-CFC process is to help identify potential showstoppers or significant issues that should not be published, rather than to complete a comprehensive review. After our break we will develop a plan for a deeper COGA TF review of both Sections 3 and 4.

---

The details:

    Section 3: Conformance, Developing

  *   A formal Pre-CFC (Call for Consensus) was started this week via an email titled “Action: Review Pre-CFC Section 3 Conformance before end of day August  30th” sent by Rachael Bradley-Montgomery.

  *   It continues to have open questions, particularly around the distinction between core and supplemental requirements and the role of core assertions.

  *   Links and feedback details are in Rachael’s email.


   Section 4, Exploratory

  *   Several areas are rough drafts and not final decisions. This includes the reporting tiers, the current definition of "harm", and the functional performance statements (expanded) list.

  *
We spent a considerable amount of time thinking about the functional performance statements. Some of the wording felt cobbled together, incomplete, and potentially insensitive. We know that was not the intention of the editors and we’d like to spend time working on recommendations (GitHub issues) in the coming months focused on refining the list.
  *
As of this email, I don’t see Rachael’s email about the pre-CFC for Section 4: Progress towards and beyond conformance, Exploratory. Be on the look out for that email with links and feedback details.


Thank you for your continued engagement and any feedback you want to share for these reviews as we move through this accelerated review period.

Len

--
Len Beasley, CPACC, (He, Him)
Domain Expert, Accessibility & Inclusive Design
W3C Accessibility Guidelines Working Group, COGA Task Force

918 630 5419
Colorado (MT)
[Aetna]
CONFIDENTIALITY NOTICE: This communication and any attachments may contain confidential and/or privileged information for the use of the designated recipients named above. If you are not the intended recipient, you are hereby notified that you have received this communication in error and that any review, disclosure, dissemination, distribution or copying of it or its contents is prohibited. If you have received this communication in error, please notify the sender immediately by email or telephone and destroy all copies of this communication and any attachments.

 NOTICE TO RECIPIENT OF INFORMATION:
This e-mail may contain confidential or privileged information. If you think you have received this e-mail in error, please advise the sender by reply e-mail and then delete this e-mail immediately.  

This e-mail may also contain protected health information (PHI) with information about sensitive medical conditions, including, but not limited to, treatment for substance use disorders, behavioral health, HIV/AIDS, or pregnancy. This type of information may be protected by various federal and/or state laws which prohibit any further disclosure without the express written consent of the person to whom it pertains or as otherwise permitted by law. Any unauthorized further disclosure may be considered a violation of federal and/or state law. A general authorization for the release of medical or other information may NOT be sufficient consent for release of this type of information.

Thank you. Aetna